Anti-inflammatory effect of extract and fractions from the leaves of Byrsonima intermedia A. Juss. in rats  by Moreira, Lucimara Q. et al.
A
i
L
M
a
b
c
a
A
R
R
2
A
A
K
A
B
C
C
F
M
1
B
m
t
c
C
c
s
1
d
f
0
dJournal of Ethnopharmacology 138 (2011) 610– 615
Contents lists available at SciVerse ScienceDirect
Journal  of  Ethnopharmacology
jo ur nal homep age : www.elsev ier .com/ locate / je thpharm
nti-inﬂammatory  effect  of  extract  and  fractions  from  the  leaves  of  Byrsonima
ntermedia  A.  Juss.  in  rats
ucimara  Q.  Moreiraa, Fabiana  C.  Vilelab, Lidiane  Orlandib,  Danielle  F.  Diasa,  Ana  Laura  A.  Santosa,
arcelo  A.  da  Silvaa,  Renato  Paivac,  Geraldo  Alves-da-Silvaa, Alexandre  Giusti-Paivab,∗
Faculty of Pharmaceutical Sciences, Federal University of Alfenas, Alfenas – MG, Brazil
Institute of Biomedical Sciences, Federal University of Alfenas, Alfenas – MG, Brazil
Department of Biology, Federal University of Lavras, Lavras – MG, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 20 June 2011
eceived in revised form
8 September 2011
ccepted 3 October 2011
vailable online 10 October 2011
eywords:
nti-inﬂammatory activity
yrsonima intermedia
atechin
hromatographic ﬁngerprints
lavonoids
alphigiaceae
a  b  s  t  r  a  c  t
Aim  of the  study:  Byrsonima  intermedia  is  commonly  used  for its antiseptic,  antimicrobial,  and  anti-
inﬂammatory  properties  in the  treatment  of  diarrhea  and  dysentery  in Brazilian  folk  medicine.  The
purpose  of  this  study  was  to  examine  the anti-inﬂammatory  activity  of  the  aqueous  extract  and  fractions
of  Byrsonima  intermedia  leaves.
Materials  and  methods:  Rats  with  carrageenan-induced  paw  edema  and  ﬁbrovascular  tissue  growth,  which
was  induced  by  subcutaneous  implantation  of a cotton  pellet,  were  used  as  acute  and  chronic  animal  mod-
els of inﬂammation  to investigate  the  anti-inﬂammatory  effects  of  the  aqueous  extract  and  the  individual
ethyl  acetate  (EtOAc)  and  aqueous  fractions  of  Byrsonima  intermedia  and  catechin.  High-performance  liq-
uid chromatography  (HPLC)  was  used  to  determine  the  ﬁngerprint  chromatogram  of  the  aqueous  extract
and fractions  of  Byrsonima  intermedia.
Results:  The  crude  aqueous  extract  at test  doses  of  30–300  mg/kg  p.o.  clearly  demonstrated  anti-
inﬂammatory  effects  by reducing  carrageenan-induced  paw  edema,  as  did  the ethyl  acetate  (100  mg/kg)
and aqueous  fractions  (30–100  mg/kg).  In the  chronic  inﬂammation  rat  animal  model  with  ﬁbrovascu-
lar  tissue  growth,  the  aqueous  extract  of  Byrsonima  intermedia  (BiAE)  at doses  of  30–300  mg/kg  and  the
individual  EtOAc  and  aqueous  fractions  at doses  of 30–100  mg/kg  and  catechin  signiﬁcantly  reduced  the
formation  of  granulomatous  tissue.  The  presence  of  catechin  and  phenolic  compounds  in the  extract  and
fractions  of Byrsonima  intermedia  was  conﬁrmed  using  HPLC.
Conclusion:  BiAE  and  the  individual  EtOAc  and  aqueous  fractions  of  Byrsonima  intermedia  exhibited
chronic  and  acute  anti-inﬂammatory  efﬁcacy  in  rats,  which  supports  previous  claims  of  its  use  in  tradi-
tional  medicine.. Introduction
The biodiversity of Brazilian is broad and several native
razilian plant species have a long history of use in traditional
edicine. These traditional medicinal plants contain compounds
hat may  not only exhibit a broad range of therapeutic efﬁ-
acy but also be useful in modern medicine. The Brazilian
errado (Neotropical Savanna) is one of the most biogeographi-
ally diverse regions of the world; it contains numerous native
pecies of vascular plants (Blatt et al., 1998; Mendonc¸ a et al.,
998). Many of these plants are commonly used in traditional
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medicine for the treatment of several ailments (Blatt et al., 1998;
Mendonc¸ a et al., 1998), including infectious and inﬂammatory dis-
eases.
The genus Byrsonima belongs to the Malpighiaceae family of
ﬂowering plants, and it is widely distributed throughout tropical
America. Byrsonima intermedia A. Juss. (Byrsonima intermedia),
which is popularly known as “murici-pequeno,” is native to
the Brazilian Cerrado (Anderson, 1979; Nogueira et al., 2007;
Sannomiya et al., 2007; Agra et al., 2008). Byrsonima intermedia
leaves are traditionally used for the treatment of fever, tuber-
culosis, fungal and bacterial infections as well as dermal and
gastrointestinal diseases (Nogueira et al., 2007; Agra et al., 2008).
Previous studies have shown that the methanol extract of Byrson-
Open access under the Elsevier OA license. ima intermedia exhibits antimicrobial activity (Michelin et al., 2008;
Pavan et al., 2009). The chemical constituents of the methanol
extract of Byrsonima intermedia leaves has been shown to contain
ﬂavonoids, such as catechin, quercetin-3-O--arabinopyranoside,
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uercetin-3-O--galactopyranoside and amentoﬂavone
Sannomiya et al., 2007).
Based on the extensive use of Byrsonima intermedia in tra-
itional medicine, the aim of this work was to evaluate the
nti-inﬂammatory effects of the aqueous extract and fractions of
yrsonima intermedia leaves in acute and chronic inﬂammatory
nimal models.
. Material and methods
.1. Plant material
Byrsonima intermedia leaves were collected in November de
009 in Ijaci (Minas Gerais, Brazil). Botanical identiﬁcation was
one in the Laboratory of Tissue Culture Plants of the Federal Uni-
ersity of Lavras (Lavras, Minas Gerais, Brazil) by Dr. Renato Paiva.
 voucher specimen of collected Byrsonima intermedia leaves was
eposited at the herbarium of the Federal University of Lavras
voucher 17.601).
.2. Preparation of the plant extracts and reference drugs
Byrsonima intermedia leaves were air dried at 40 ◦C and then
round into a powder. The powder was extracted with hot deion-
zed water (100 ◦C) for 20 min. The aqueous extract was then
yophilized (45% yield) and stored under light protection at −5 ◦C.
he lyophilized Byrsonima intermedia leaf extract was partitioned
n succession with Ethyl acetate (EtOAc) and water, which yielded a
ried EtOAc fraction (13.1% yield) and a water-soluble fraction. The
ater-soluble fraction residue was used to determine the bioac-
ivity of Byrsonima intermedia.  Doses of 30, 100, and 300 mg/kg
f Byrsonima intermedia aqueous extract (BiAE); 10, 30, and
00 mg/kg of the EtOAc and aqueous fractions and 75 mg/kg cat-
chin; and 0.2 mg/kg dexamethasone and 10 mg/kg indomethacin
as reference controls) were suspended in a 1% sodium car-
oxymethylcellulose (CMC) suspension in distilled water prior to
eing administered orally to rats (Vilela et al., 2010). Control ani-
als were exposed to the same experimental conditions as the test
roups, except the drug treatments were replaced with appropriate
olumes of the CMC  dosing vehicle (10 ml/kg).
.3. Thin-layer chromatography ﬁngerprints
Thin layer chromatography (TLC) of the lyophilized BiAE and
he EtOAc and aqueous fractions was performed on 0.25 mm
hick Merck Silica gel 60 F254-precoated TLC plates, developed
ith CHCl3/MeOH/H2O (43:37:20, v/v/v) and visualized as previ-
usly described (Wagner and Bladt, 1996). Brieﬂy, TLC plates were
prayed and developed with natural products-polyethylene glycol
NP/PEG) reagent, and the ﬂuorescent ﬂavonoids were detected
nder ultraviolet (UV) light with a 365 nm wavelength and then
ompared to catechin, rutin, and quercetin standards (1:1, w/v).
.4. Analysis of the BiAE and the individual EtOAc and aqueous
ractions using high performance liquid chromatography
High performance liquid chromatography (HPLC) analysis of the
iAE and the individual EtOAc and aqueous fractions were per-
ormed using a Shimadzu UFLC 20A using a Shimadzu CLC-ODS
250 – 4.6 mm)  C18 column with a 5 m particle size. Mobile
hases were composed of a (A) 0.5 mM/l  aqueous acetic acid and
B) 0.5% acetic acid in methanol. The gradient of the mobile phases
A:B) used for separation were a linear gradient 0–30 min  (90:10 to
:100) and 50 min  (0:100) with a solvent ﬂow rate of 1.0 ml/min,
n injection volume of 25 l at a concentration of 1 mg/ml. The elu-
nt was detected with a photodiode array detector (DAD) with UVrmacology 138 (2011) 610– 615 611
light at 268 nm.  LC solution software (Shimadzu) was used for data
collection.
2.5. Experimental procedures
2.5.1. Animals
Adult male Wistar rats weighing 180–220 g (n = 8 animals per
group) were obtained from the Central Animal Facility of the Fed-
eral University of Alfenas (Alfenas, Minas Gerais, Brazil) and housed
in a controlled 12 h light–dark room (lights on at 06:00 am)  at
23 ± 1 ◦C with ad libitum access to water and food. The animals were
habituated to the housing facilities for at least one week prior to the
beginning of any experiments. All experiments were conducted in
accordance with the Declaration of Helsinki on the welfare of exper-
imental animals with the approval of the Ethics Committee of the
Federal University of Alfenas (#221/2009).
2.5.2. Carrageenan-induced paw edema in rat
Rats were fasted overnight with free access to water, and then
pedal inﬂammation was  induced by treatment of the right hind
paw with carrageenan as previously described (Vinegar et al., 1969;
Vilela et al., 2010). Paw edema was measured with a plethys-
mometer (Model 7140, Ugo Basile, Italy). The basal volume of the
right hind paw was  determined prior to the administration of any
drug. After the basal paw volume was measured, the animals were
divided into experimental treatment groups (n = 8 per group) so
that the mean basal paw volume of each group was similar. Vehi-
cle, BiAE, EtOAc, aqueous fractions, catechin or indomethacin was
administered orally 1 h prior to the intraplantar injection of 1 mg
carrageenan in 100 l. The paw volume was measured 1, 2, 3 and
4 h following the injection of carrageenan. Results are presented as
the change of paw volume (ml) in relation to the basal paw volume.
2.5.3. Cotton pellet-induced granuloma tissue formation test
The effect of BiAE, the individual EtOAc and aqueous fractions
or catechin on the chronic and proliferative phases of inﬂam-
mation was  assessed using a cotton pellet induced granuloma
tissue formation rat model, as previously described by Swingle and
Shideman (1972).  Rats were anesthetized with tribromoethanol
(250 mg/kg; i.p.), and then an autoclave sterilized cotton pel-
let that weighed 40 mg  was  implanted subcutaneously, one on
each side of the abdomen, through a small ventral incision in the
abdomen of the animal. After the implantation of the cotton pellet,
each treatment group of rats (n = 8 per group) was administered
vehicle, dexamethasone (0.2 mg/kg), BiAE (30–300 mg/kg), EtOAc
fraction (10–100 mg/kg), aqueous fraction (10–100 mg/kg) or cat-
echin (75 mg/kg) once daily for seven consecutive days. Eight days
after implantation of the cotton pellet the animals were euthanized
with halothane. Each implanted cotton pellet was removed with the
surrounding ﬁbrovascular tissue and dried at 40 ◦C for 24 h; after-
ward, the dry weight was measured. Results are expressed as the
difference between the initial implanted cotton pellet weight and
ﬁnal dry mass of the cotton pellet and ﬁbrovascular tissue.
2.6. Statistical analysis
All data was  analyzed using GraphPad statistical software Ver-
sion 4.0 and expressed as mean ± standard error of the mean (SEM)
Statistically signiﬁcant differences between treatment groups were
calculated using analysis of variance (ANOVA) followed by a
Dunnett’s post hoc test. p-Values less than 0.05 (p < 0.05) were
considered signiﬁcant.
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. Results
TLC ﬁngerprints of each of the extracts from Byrsonima interme-
ia exhibited a speciﬁc chromatogram of catechin and ﬂavonoids.
he chromatogram of BiAE (Fig. 1A) and the EtOAc (Fig. 1B) and
queous (Fig. 1C) fractions as well as a mixture of phenolic com-
ounds that was  composed of catechin and ﬂavonoids were further
xamined using HPLC with a DAD with 268 nm wavelength. The
resence of phenolic compounds in the BiAE and each of the
ndividual EtOAc and aqueous fractions was conﬁrmed by UV spec-
rometry (190–400 nm)  and compared with standards. The HPLC
hromatogram of BiAE had the peak at retention time (TR) of
3.17 min  was characterized for catechin and the peak at 11.30 min
as catechin derivative that exhibited absorption maxima (max)
ands of decreasing intensity at 279 nm.  The others peaks at
6.17 min, 17.69 min, 18.12 min  and 18.66 min  were exhibited UV
bsorption for some ﬂavonoids derivatives. The EtOAc fraction had
he catechin peak at 13.34 min  with max at 279 nm and two peaks
f catechin derivatives at 10.98 min  and 12.91 min. The peaks at
7.38 min, 17.81 and 18.36 min  had exhibited UV absorption for
avonoid derivatives. Finally, the aqueous fraction had the peaks
t 11.14 min  and 13.50 min  with UV absorption similar to catechin
erivatives (max at 279) and the peaks at 12.64 min, 16.05 min  and
7.97 min  with absorption like ﬂavonoids derivatives. The catechin
nd derivatives content of BiAE and EtOAc and aqueous fractionsA) and its ethyl acetate fraction (B) and aqueous fraction (C), which were monitored
were, respectively, 10%, 8% and 18%. The ﬂavonoids derivatives
content were 42% (BiAE), 44% (EtOAc fraction) and 40% (aqueous
fraction).
The acute and chronic anti-inﬂammatory effects of each of the
Byrsonima intermedia extract and fractions and catechin are shown
in Figs. 2 and 3, respectively. Three hours after the injection of car-
rageenan, the oral administration of 30, 100 and 300 mg/kg BiAE
reduced (F4,32 = 7.77; p = 0.0002; Fig. 2A) the edematous response
by 41.8%, 87.3% and 86.7%, respectively. The reduction in inﬂamma-
tion by BiAE was comparable to a 10 mg/kg dose of indomethacin,
which reduced edema inﬂammation by 90.0%. The EtOAc fraction
(F4,29 = 8.43; p = 0.00002; Fig. 2B) had signiﬁcant anti-inﬂammatory
activity at a dose of 100 mg/kg and the aqueous fraction had
signiﬁcant anti-inﬂammatory activity at doses 30 and 100 mg/kg
(F4,24 = 9.925; p = 0.0003 and F4,30 = 17.1; p < 0.0001, respectively;
Fig. 2C). For catechin 75 mg/kg the anti-inﬂammatory effect was
24% reducing the edematous response (F3,21 = 26.3; p < 0.0001;
Fig. 2D).
Fig. 3 shows the effects of BiAE and its fractions and cate-
chin on granulomatous tissue growth. Oral administration of BiAE
at doses of 30, 100 and 300 mg/kg produced a signiﬁcant reduc-
tion in the formation of granulomatous tissue on the implanted
cotton pellets (F4,32 = 11.75; p < 0.0001; Fig. 3A) when compared
to vehicle control. A signiﬁcant decrease in granulomatous tissue
growth was observed following oral administration of all doses
L.Q. Moreira et al. / Journal of Ethnopharmacology 138 (2011) 610– 615 613
0 1 2 3 4
0.0
0.2
0.4
0.6
Vehicle 30 mg/kg
100 mg/kg
300 mg/kg
Indomethacin
**
**
** **
**
**
**
Crude extract of leaves
**
**
A
Time (h)
E
de
m
a 
vo
lu
m
e 
(m
l)
0 1 2 3 4
0.0
0.2
0.4
0.6
Vehicle 10 mg/kg
30 mg/kg
100 mg/kg
Indomethacin
*
**
** **
**
Ethyl acetate fractionB
Time (h)
E
de
m
a 
vo
lu
m
e 
(m
l)
0 1 2 3 4
0.0
0.2
0.4
0.6
Vehicle 10 mg/kg
30 mg/kg
100 mg/kg
Indomethacin
**
**
**
**
**
**
Aqueous fraction
** **
C
Time (h)
E
de
m
a 
vo
lu
m
e 
(m
l)
0 1 2 3 4
0.0
0.3
0.6
0.9 Vehicle
Catechin 75 mg/kg
Indomethacin
**
*
***
***
***
D
Time (h)
E
de
m
a 
vo
lu
m
e 
(m
l)
F eaves 
( enote
o
t
i
r
a
c
2
F
4
e
a
a
i
b
m
m
i
s
mig. 2. Evaluation of the anti-inﬂammatory efﬁcacy of the crude aqueous extract l
C)  and catechin (D) in a carrageenan induced paw edema rat model. The asterisks d
f the EtOAc (F4,26 = 11.49; p < 0.0001; Fig. 3B) and aqueous frac-
ions (F4,28 = 11.84; p < 0.0001; Fig. 3C). The effect of BiAE and the
ndividual EtOAc and aqueous fractions was comparable to the
eduction of the formation of granulomatous tissue following the
dministration of dexamethasone. Animals that were treated with
atechin showed a reduction of granulomatous tissue growth of
6% when compared to vehicle control (F3,20 = 31.5; p < 0.0001;
ig. 3D).
. Discussion
Anti-inﬂammatory compounds function by inhibiting speciﬁc
nzymes and/or by acting as an antagonist of speciﬁc receptors
nd the translational response of mediators that are involved in
n inﬂammatory response. Widely used cyclooxygenase (COX)
nhibitors (Chan and Carter, 2010) and corticosteroids function by
locking the production and/or action of several pro-inﬂammatory
ediators (Serhan, 2008). Corticosteroids are effective in the treat-
ent of inﬂammatory diseases, but their long-term use may  require
ncreased doses and cause unwanted side-effects. It has been
hown that prolonged treatment with non-selective COX inhibitors
ay  cause gastrointestinal bleeding or kidney damage, and theof Byrsonima intermedia (A) and its ethyl acetate fraction (B) and aqueous fraction
s the level of signiﬁcance when compared to the control group: *p < 0.05; **p < 0.01.
more selective COX-2 inhibitors may  cause an increase in the risk
of development of cardiovascular disease (Mukherjee et al., 2001).
Therefore, there is an urgent need to identify effective new anti-
inﬂammatory therapies that have less possibility of aversive side
effects (Barkin et al., 2010; Brueggemann et al., 2010; Capone et al.,
2010).
Natural compounds that are derived from many plants and
exhibit various anti-inﬂammatory mechanisms of action can be
used to treat inﬂammatory diseases (Calixto et al., 2003; Rios
et al., 2009). Many of the plants that are used in traditional
medicine exhibit pharmacological properties and may  offer signif-
icant potential as therapeutic agents. Tea made from small-murici
has been popularly used in diarrhea and dysentery as well as for
antifungal and anti-inﬂammatory activity (Rodrigues and Carvalho,
2001; Orlandi et al., 2011).
The present study examined the anti-inﬂammatory properties
of the aqueous extract and the individual EtOAc and aqueous frac-
tions of Byrsonima intermedia leaves.Carrageenan-induced paw edema is an acute inﬂamma-
tory animal model that is effective in studying orally active
anti-inﬂammatory drugs (Winter et al., 1962; Morris, 2003).
The development of carrageenan-induced edema is commonly
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tig. 3. The anti-inﬂammatory efﬁcacy of the crude aqueous extract leaves of Byrson
D)  in the reduction of granulomatous tissue formation. The asterisks denote the le
istinguished by the presence of the early exudative stage of
nﬂammation, which is one of the most important characteristics
f inﬂammatory pathology (Morris, 2003). Carrageenan-induced
dema caused the release of several inﬂammatory mediators; the
nitial phase of inﬂammation includes the release of bradykinin,
istamine and serotonin by cells near the carrageenan injection
oint. Several hours after treatment with carrageenan, there is an
ncrease in the release of prostaglandins by macrophages, which
re mediated by bradykinin and leukotrienes (Seibert et al., 1994;
eno and Oh-ishi, 2002; Passos et al., 2004).
The induction of granulomas by subcutaneous insertion of a
otton pellet into a rat is widely used to study the transudative
nd proliferative phases of chronic inﬂammation. In this study, the
queous extract and the EtOAc and aqueous fractions obtained from
yrsonima intermedia leaves and catequin decreased the wet and
ry weight of the cotton pellets compared to control groups. This
eduction in inﬂammatory granuloma tissue may  be due to both the
bility of Byrsonima intermedia to reduce the number of ﬁbroblasts
nd the synthesis of collagen and mucopolysaccharides, which are
atural proliferative agents involved in the formation of granuloma
issue.termedia (A) and its ethyl acetate fraction (B) and aqueous fraction (C) and catechin
signiﬁcance when compared to the control group: *p < 0.05; **p < 0.01.
The TLC and HPLC analysis of BiAE and the individual EtOAc
and aqueous fractions showed that they contained phenolic com-
pounds, which were further identiﬁed as catechin and ﬂavonoids.
The anti-inﬂammatory mechanism of action of phenols is caused
by a reduction of NF-B transcription by the inhibition of IB kinase
activity and the reduction of the expression of several target genes
that are indispensable to the inﬂammatory process (Yang et al.,
1998; Pan et al., 2000; Ichikawa et al., 2004). Catechins inhibit
the adhesion and migration of neutrophils through endothelial cell
monolayers by several mechanisms, which include the suppres-
sion of the production of chemokines at the site of inﬂammation
(Hofbauer et al., 1999; Takano et al., 2004), reduced expression
of cytokine-induced vascular cell adhesion protein 1 (VCAM-1) in
endothelial cells and the reduction of monocyte adhesion to the
endothelial monolayer, which is independent of NF-B activation
(Ludwig et al., 2004). Earlier studies showed that catechin inhibits
secondary inﬂammatory reactions in rats with chronic inﬂam-
mation. Catechin modulates the production of proinﬂammatory
cytokines and reduced the level of PGE2 in rats (Tang et al., 2007).
The anti-inﬂammatory properties that were observed in this
study may  be due to the pharmacological activity of one or a
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ombination of several of the compounds present in Byrsonima
ntermedia,  since the BiAE and fractions exercised greater anti-
nﬂammatory activity compared to that catechin could be due
o the synergistic effect. Reports have shown that crude plant
xtracts are more active pharmacologically than their isolated
ctive principles (Hamburger and Hostettmann, 1991). This may
e due to the synergistic effects of the various components present
n the extracts. Other studies report these effects of phytochemicals
ncluding catechin and derivatives with various other phytochem-
cals (HemaIswarya and Doble, 2006).
In conclusions, the results presented in this study suggests that
he aqueous extract that was obtained from Byrsonima interme-
ia leaves exhibited potent anti-inﬂammatory activity in acute and
hronic inﬂammatory animal models. The precise mechanisms that
re involved in the production of the anti-inﬂammatory response of
yrsonima intermedia extracts are not completely understood, but
hey may  be caused by the presence of catechin and ﬂavonoids in
he aqueous extract of Byrsonima intermedia leaves. These results
onﬁrm the possible use of Byrsonima intermedia in traditional
edicine as a therapeutic agent for the treatment of inﬂammatory
iseases.
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